Screener
Staar Surgical STAA Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 76.6%+4.9pp | 76.9%+2.9pp | 76.2%-0.1pp | 73.9%-4.9pp | 71.7%-7.5pp | |
| Operating margin | 4%+52.9pp | -9.1%+15.2pp | -38.3%-34.3pp | -42%-49.5pp | -48.8%-56.7pp | |
| Net margin | 1.1%+43.6pp | -7.2%+18.2pp | -33.6%-27.2pp | -41.8%-48.2pp | -42.4%-47.4pp | |
| Returns | ||||||
| Return on equity | 1.1%+26.6pp | -6%+13.2pp | -21.7%-16.5pp | -24.6%-30.0pp | -25.6%-29.9pp | |
| Return on invested capital | 3%+50.4pp | -11.2%+21.2pp | -35.2%-30.4pp | -37.2%-42.6pp | -47.4%-53.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.3× | 0.6×+0.1× | 0.5×-0.1× | 0.5×-0.2× | 0.5×-0.2× | |
| Liquidity | ||||||
| Current ratio | 4.7×-0.3× | 5.1×+0.3× | 4.5×-0.7× | 5.2×-0.8× | 4.9×-0.9× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -5.1×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $7.10+4.4% | $6.92-2.4% | $6.94-14.2% | $7.00-18.7% | $6.80-17.2% | |
| Valuation | ||||||
| Market capitalization | $1.12B-17.1% | $1.31B+47.4% | $935.48M-21.5% | $1.28B-10.5% | $887.26M-56.0% | |
| Price / earnings | 292.3×— | —— | —— | —— | —— | |
| Price / sales | 3.3×-2.7× | 4.5×+1.3× | 3.9×+0.1× | 5.5×+1.4× | 4×-2.1× | |
| Price / book | 3.1×-0.9× | 3.7×+1.2× | 2.7×-0.3× | 3.6×+0.3× | 2.6×-2.3× | |
| EV / EBITDA | 45.4×— | —— | —— | —— | —— |
FAQ
- What are Staar Surgical's profit margins?
- Staar Surgical (STAA) runs a 76.6% gross margin and a 4.0% operating margin, with a 1.1% net margin.
- Where do Staar Surgical's ratios come from?
- Every ratio is computed from Staar Surgical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
